• Shortening Dual Antiplatelet Therapy Ups MI Risk in ACS

    6 monthes ago - By Medscape

    Although the SMART-DATE trial met its noninferiority composite endpoint, increased MI with shorter treatment led to the conclusion that 12 months or longer of DAPT should remain standard of care.
    Medscape Medical News
    Read more ...